StonvexLoading…
StonvexStonvexStonvexCore line items from PMTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $147.11M | $543.53M | $390.48M | $252.51M |
Operating Income | $10.99M | $54.84M | $36.55M | $23.53M |
Net Income | $2.06M | $14.95M | $7.60M | $5.29M |
EPS (Diluted) | $0.17 | $1.25 | $0.64 | $0.44 |
Total Assets | $386.45M | $403.19M | $407.06M | $399.80M |
Total Liabilities | $400.46M | $420.52M | $432.72M | $428.82M |
Cash & Equivalents | $19.30M | $21.70M | $15.96M | $17.12M |
Free Cash Flow OCF − CapEx | $10.13M | $41.33M | $6.13M | $825.00K |
Shares Outstanding | 11.48M | 11.46M | 11.39M | 11.33M |